Veeva Systems Inc. (VEE.DE)
EUR 186.2
(-3.07%)
EUR 186.2
(-3.07%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 1.26 Billion USD | 16.36% |
| 2023 | 1.08 Billion USD | 20.25% |
| 2022 | 904.82 Million USD | 16.04% |
| 2021 | 779.74 Million USD | 28.63% |
| 2020 | 606.18 Million USD | 45.71% |
| 2019 | 416.01 Million USD | 26.46% |
| 2018 | 328.96 Million USD | 24.27% |
| 2017 | 264.72 Million USD | 32.0% |
| 2016 | 200.55 Million USD | 45.27% |
| 2015 | 138.05 Million USD | 53.04% |
| 2014 | 90.21 Million USD | 61.51% |
| 2013 | 55.85 Million USD | 104.51% |
| 2012 | 27.31 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 1.08 Billion USD | -0.71% |
| 2024 Q2 | 1.07 Billion USD | -0.44% |
| 2024 Q4 | 1.26 Billion USD | 49.66% |
| 2024 Q3 | 845.99 Million USD | -21.34% |
| 2024 FY | 1.26 Billion USD | 16.36% |
| 2023 Q3 | 763.92 Million USD | -12.46% |
| 2023 Q2 | 872.65 Million USD | -7.45% |
| 2023 Q1 | 942.94 Million USD | 4.21% |
| 2023 FY | 1.08 Billion USD | 20.25% |
| 2023 Q4 | 1.08 Billion USD | 42.43% |
| 2022 Q2 | 731.28 Million USD | -5.9% |
| 2022 Q3 | 598.12 Million USD | -18.21% |
| 2022 Q4 | 904.82 Million USD | 51.28% |
| 2022 FY | 904.82 Million USD | 16.04% |
| 2022 Q1 | 777.16 Million USD | -0.33% |
| 2021 FY | 779.74 Million USD | 28.63% |
| 2021 Q4 | 779.74 Million USD | 63.38% |
| 2021 Q3 | 477.26 Million USD | -14.73% |
| 2021 Q2 | 559.68 Million USD | -7.27% |
| 2021 Q1 | 603.58 Million USD | -0.43% |
| 2020 Q1 | 441 Million USD | 6.01% |
| 2020 Q2 | 414.83 Million USD | -5.93% |
| 2020 Q3 | 341.87 Million USD | -17.59% |
| 2020 Q4 | 606.18 Million USD | 77.31% |
| 2020 FY | 606.18 Million USD | 45.71% |
| 2019 FY | 416.01 Million USD | 26.46% |
| 2019 Q4 | 416.01 Million USD | 60.64% |
| 2019 Q1 | 343.21 Million USD | 4.33% |
| 2019 Q3 | 258.97 Million USD | -17.58% |
| 2019 Q2 | 314.21 Million USD | -8.45% |
| 2018 Q2 | 269.26 Million USD | -6.1% |
| 2018 Q3 | 227.74 Million USD | -15.42% |
| 2018 Q4 | 328.96 Million USD | 44.44% |
| 2018 FY | 328.96 Million USD | 24.27% |
| 2018 Q1 | 286.75 Million USD | 8.32% |
| 2017 Q2 | 222.12 Million USD | 0.4% |
| 2017 FY | 264.72 Million USD | 32.0% |
| 2017 Q4 | 264.72 Million USD | 45.0% |
| 2017 Q1 | 221.24 Million USD | 10.32% |
| 2017 Q3 | 182.56 Million USD | -17.81% |
| 2016 Q1 | 139.71 Million USD | 1.2% |
| 2016 FY | 200.55 Million USD | 45.27% |
| 2016 Q2 | 137.99 Million USD | -1.23% |
| 2016 Q4 | 200.55 Million USD | 32.77% |
| 2016 Q3 | 151.05 Million USD | 9.46% |
| 2015 Q1 | 104.83 Million USD | 16.21% |
| 2015 Q2 | 106.85 Million USD | 1.92% |
| 2015 FY | 138.05 Million USD | 53.04% |
| 2015 Q3 | 111.34 Million USD | 4.2% |
| 2015 Q4 | 138.05 Million USD | 23.99% |
| 2014 Q1 | 61.77 Million USD | 10.61% |
| 2014 Q3 | 74.64 Million USD | 14.45% |
| 2014 Q4 | 90.21 Million USD | 20.86% |
| 2014 Q2 | 65.22 Million USD | 5.57% |
| 2014 FY | 90.21 Million USD | 61.51% |
| 2013 FY | 55.85 Million USD | 104.51% |
| 2013 Q4 | 55.85 Million USD | 0.0% |
| 2012 FY | 27.31 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| DocCheck AG | 21.07 Million EUR | -5907.777% |
| CompuGroup Medical SE & Co. KGaA | 1.23 Billion EUR | -2.879% |
| MeVis Medical Solutions AG | 10.22 Million EUR | -12278.816% |
| Nexus AG | 153.13 Million EUR | -726.79% |